Table.
Incidence within 6 months after COVID-19 | Incidence within 6 months after influenza | Hazard ratio | p value | |
---|---|---|---|---|
Alzheimer's disease (G30) | 0·071% (0·050–0·10) | 0·036% (0·025–0·054) | 2·19 (1·29–3·70) | 0·0029 |
Vascular dementia (F01) | 0·063% (0·042–0·094) | 0·041% (0·029–0·060) | 1·59 (0·94–2·70) | 0·082 |
Dementia in other diseases classified elsewhere (F02) | 0·11% (0·081–0·15) | 0·055% (0·040–0·076) | 2·11 (1·37–3·23) | 0·0005 |
Unspecified dementia (F03) | 0·25% (0·20–0·31) | 0·12% (0·094–0·15) | 2·04 (1·52–2·75) | <0·0001 |
Data in parentheses are 95% CIs. Dementia subtypes are presented with their ICD-10 codes. The sum of incidences exceeds the total incidence of dementia because the same patient might be diagnosed with one subtype (eg, unspecified dementia) and then another (eg, Alzheimer's disease) within the follow-up period. No data can be shown for frontotemporal dementia and Lewy body dementia because they occurred in fewer than ten patients in each cohort (which is the minimum number to be returned by TriNetX to safeguard patients' anonymity).